Context Matters to Participate in Webinar With Oracle Health Sciences and Tufts Center for the Study of Drug Development on Integration of Real-World Data in Drug Development Strategy
February 04, 2014 08:45 ET
|
Context Matters
NEW YORK, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Context Matters announces that its CEO, Yin Ho, MD, MBA, will participate in a webinar sponsored by Oracle Health Sciences and Pharmaceutical...
Context Matters Launches the New Version of Its Reimbursement Risk Tracker Application, Featuring "Snapshots," a Dynamic, Never-Before-Seen View of the Reimbursement and Drug Development Landscape
January 22, 2014 09:15 ET
|
Context Matters
NEW YORK, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Context Matters announces the release of the new version of its flagship application, the Reimbursement Risk Tracker™ (RRT), featuring Snapshots. The...
Context Matters Makes Key Hires in Analytics and Technology
July 01, 2013 09:00 ET
|
Context Matters
NEW YORK, July 1, 2013 (GLOBE NEWSWIRE) -- Context Matters announces two key hires to enhance its data, technology and analytics platform product. Kermit E. Daniel, Ph.D. assumes the role of Chief...
Context Matters Appoints Dr. Paul Greenberg to Its Board of Advisors
June 18, 2013 09:37 ET
|
Context Matters
NEW YORK, June 18, 2013 (GLOBE NEWSWIRE) -- Context Matters announces the addition of Dr. Paul Greenberg to its Board of Advisors.
"The addition of Paul to our Board of Advisors brings significant...
Context Matters Introduces Solid Tumor Cancer Module Into Its Proprietary Reimbursement Risk Tracker(TM) at American Society of Clinical Oncology (ASCO) Conference
May 30, 2013 09:35 ET
|
Context Matters
NEW YORK, May 30, 2013 (GLOBE NEWSWIRE) -- Context Matters announces the addition of a solid tumor cancer module into its proprietary thin-client, cloud-based web application and data platform, the...
New Studies Demonstrate General Agreement in Reimbursement Decisions and the Value of Interventional Outcomes, Regardless of Location
May 21, 2013 09:30 ET
|
Context Matters
NEW YORK, May 21, 2013 (GLOBE NEWSWIRE) -- Context Matters presented two studies at ISPOR's 18th Annual International Meeting in New Orleans. The first, a presentation, demonstrated agreement by more...
Despite Rising Pharmaceutical Industry Interest in Real World Outcomes, Few Patient-Reported Outcomes Are Included in Diabetes Clinical Trials According to a Context Matters/Pfizer Study
May 20, 2013 09:30 ET
|
Context Matters
NEW ORLEANS, May 20, 2013 (GLOBE NEWSWIRE) -- Despite rising interest in real world outcomes, a recent study performed by Context Matters and Pfizer demonstrates that less than ten percent of diabetes...
Context Matters to Demonstrate Flagship Product Reimbursement Risk Tracker at BIO Conference
April 18, 2013 08:45 ET
|
Context Matters
NEW YORK, April 18, 2013 (GLOBE NEWSWIRE) -- Context Matters announces that it will be an exhibitor at the BIO Conference, where it will be demonstrating its Reimbursement Risk Tracker™, a...
Context Matters Introduces Real-World Evidence Into Its Proprietary Reimbursement Risk Tracker(TM)
April 08, 2013 08:35 ET
|
Context Matters
NEW YORK, April 8, 2013 (GLOBE NEWSWIRE) -- Context Matters announces the addition of patient-reported outcomes (PROs) to its proprietary data platform, the Reimbursement Risk Tracker™, which...
Use of "Efficacy" and "Effectiveness" Often Misleading and May Skew Reimbursement Decisions
November 06, 2012 09:30 ET
|
Context Matters
NEW YORK, Nov. 6, 2012 (GLOBE NEWSWIRE) -- A recent global analysis of product evaluations for Health Technology Assessments – which are often influential in decision making for approving and/or...